NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $268,574 | +9.7% | 2,662 | +0.0% | 0.04% | -2.2% |
Q1 2023 | $244,837 | -31.6% | 2,661 | -32.5% | 0.05% | -37.8% |
Q4 2022 | $357,737 | +33.5% | 3,943 | +11.8% | 0.07% | +37.0% |
Q3 2022 | $268,000 | -10.7% | 3,528 | -0.6% | 0.05% | -5.3% |
Q2 2022 | $300,000 | -39.8% | 3,550 | -37.4% | 0.06% | -28.8% |
Q1 2022 | $498,000 | +7.1% | 5,671 | +6.8% | 0.08% | +17.6% |
Q4 2021 | $465,000 | -13.4% | 5,309 | -19.1% | 0.07% | -18.1% |
Q3 2021 | $537,000 | +1.7% | 6,562 | +13.0% | 0.08% | -1.2% |
Q2 2021 | $528,000 | +105.4% | 5,808 | +93.6% | 0.08% | +78.7% |
Q1 2021 | $257,000 | -9.5% | 3,000 | -0.5% | 0.05% | -20.3% |
Q4 2020 | $284,000 | -33.2% | 3,015 | -38.0% | 0.06% | -46.4% |
Q2 2020 | $425,000 | +40.7% | 4,862 | +32.7% | 0.11% | +17.0% |
Q1 2020 | $302,000 | +38.5% | 3,663 | +45.8% | 0.09% | +20.5% |
Q4 2019 | $218,000 | 0.0% | 2,513 | 0.0% | 0.08% | 0.0% |
Q3 2019 | $218,000 | -3.1% | 2,513 | +3.1% | 0.08% | -8.2% |
Q2 2019 | $225,000 | +294.7% | 2,438 | +249.3% | 0.08% | +214.8% |
Q2 2017 | $57,000 | – | 698 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
Elefante Mark B | 4,579 | $333,000 | 4.02% |
COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |